Georgina Long

Prof. Georgina Long is co-director of Melanoma Institute Australia and a global leader in melanoma treatment including CNS disease. She led the ABC trial evaluating nivolumab plus ipilimumab in active melanoma brain metastases, demonstrating remarkable intracranial responses. Her work has established immunotherapy as a first-line option for melanoma brain metastases and defined criteria for intracranial response assessment.